340 related articles for article (PubMed ID: 10914624)
1. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
2. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
4. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
5. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
6. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
7. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
8. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
[TBL] [Abstract][Full Text] [Related]
10. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
14. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
15. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
16. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
MacDonald ML; Wagner RM; Slotnick RN
Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
[TBL] [Abstract][Full Text] [Related]
18. Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
[TBL] [Abstract][Full Text] [Related]
19. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
[TBL] [Abstract][Full Text] [Related]
20. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
Christiaens GC; Hagenaars AM; Akkerman C; De France HF
Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
